Provided by Tiger Trade Technology Pte. Ltd.

Insulet

258.07
+11.734.76%
Pre-market: 258.00-0.0700-0.03%08:23 EST
Volume:2.07M
Turnover:543.81M
Market Cap:18.15B
PE:74.79
High:275.10
Open:266.00
Low:256.62
Close:246.34
52wk High:354.88
52wk Low:230.05
Shares:70.35M
Float Shares:70.08M
Volume Ratio:2.01
T/O Rate:2.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.45
EPS(LYR):5.78
ROE:19.68%
ROA:8.74%
PB:13.12
PE(LYR):44.62

Loading ...

Truist Financial Sticks to Their Buy Rating for Insulet (PODD)

TIPRANKS
·
25 mins ago

Goldman Sachs Sticks to Its Buy Rating for Insulet (PODD)

TIPRANKS
·
1 hour ago

Insulet price target lowered to $340 from $380 at Citi

TIPRANKS
·
1 hour ago

Insulet price target raised to $286 from $274 at Barclays

TIPRANKS
·
2 hours ago

Insulet Corp : Leerink Partners Cuts Target Price to $360 From $386

THOMSON REUTERS
·
9 hours ago

Insulet: Strong Q4 Execution and Encouraging 2026 Outlook Offset by Valuation and Competitive Pressures, Justifying Hold Rating

TIPRANKS
·
16 hours ago

Insulet: Sustained Growth Runway and Underappreciated Long‑Term Upside Support Buy Rating

TIPRANKS
·
17 hours ago

Insulet Price Target Maintained With a $380.00/Share by BTIG

Dow Jones
·
18 hours ago

Early notable gainers among liquid option names on February 18th

TIPRANKS
·
Yesterday

Stock Track | Insulet Soars 9.57% Intraday on Strong Q4 Earnings Beat, Robust Omnipod Demand and Upbeat Guidance

Stock Track
·
Yesterday

Insulet Shares up 10% After Q4 Results Beat

THOMSON REUTERS
·
Yesterday

BUZZ-Insulet climbs on better-than-expected quarterly results

Reuters
·
Yesterday

Insulet Shares up 8% Premarket After Q4 Results Beat

THOMSON REUTERS
·
Yesterday

Stock Track | Insulet Soars 5.14% in Pre-market on Strong Q4 Results, Robust Guidance and Share Buyback Plan

Stock Track
·
Yesterday

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Reuters
·
Yesterday

Insulet Q4 revenue beats on Omnipod strength

Reuters
·
Yesterday

Insulet Publishes Corporate Presentation on Omnipod Growth, AID Leadership, and Product Pipeline

Reuters
·
Yesterday

Insulet Q4 Adj. EPS $1.55 Beats $1.45 Estimate, Sales $783.800M Beat $768.691M Estimate

Benzinga
·
Yesterday

BRIEF-Insulet Q4 Revenue USD 783.8 Million Vs. IBES Estimate USD 768.7 Million

Reuters
·
Yesterday

Insulet Reports Fourth Quarter and Full Year 2025 Results

THOMSON REUTERS
·
Yesterday